RSS-Feed abonnieren

DOI: 10.1055/a-2773-9382
Association Between Rapid Progression, Early Mortality, and Imaging in Neonatal-Onset Alexander Disease
Autor*innen
Abstract
Alexander disease represents a rare genetic leukodystrophy caused by abnormal astrocytic accumulations of intracytoplasmic proteinaceous inclusions with astrocyte dysfunction. With neonatal onset, survival ranges from 1.5 months to more than 7.5 years, with a possible association between the underlying point mutation, the level of protein accumulation in the cerebral white matter, disease progression, and survival time. We describe the clinical and cerebral imaging features of a female newborn with neonatal-onset Alexander disease caused by a heterozygous de novo point mutation c.1106T > C; p.(Leu369Pro) located in the coil 2B area of the glial fibrillary acidic protein (GFAP). Early-onset seizures, lethargy, and rapid loss of spontaneous movements were accompanied by rapidly evolving brain morphologic abnormalities and early death. The progression of cerebral abnormalities was monitored by magnetic resonance imaging and serial cranial ultrasound exams. As shown in this case study and the accompanying literature review, rapid accumulation of GFAP, as indicated by volume expansion of affected structures on brain imaging, combined with early onset of seizures and rapid clinical deterioration, seems to be associated with poor prognosis. In this case, high-resolution ultrasound offered an easily accessible, serial bedside imaging tool for the detection and follow-up of pathognomonic features of Alexander disease. We observed a close genotype-phenotype interaction in neonatal-onset Alexander disease, with the c.1106T > C; p.(Leu369Pro) mutation in coil2B associated with early death.
Keywords
neonatal leukodystrophy - neonatal onset - Alexander disease - CUS - white matter disease - neonatal seizuresData Availability Statement
The datasets supporting the conclusions of this article are included within the article.
Contributors' Statement
S.S. designed the study, carried out data retrieval, extracted literature, interpreted the results, wrote the initial draft, and created figures. L.S.D.V. and S.J.S. scored the CUS images. K.S. and N.R.D. scored the MR images. N.B. carried out statistical analyses, interpreted the results, and revised the initial draft. L.S.D.V., M.H.L., F.B., and T.R. interpreted the patient imaging data regarding the initial diagnosis. J.L. carried out genetic analysis. All authors revised the initial draft and read/approved the final manuscript.
Ethical Approval
The authors adhere to the ethical standards described by the Committee on Publication Ethics and the International Committee of Medical Journal Editors. The infant's parents provided written informed consent for publication.
Publikationsverlauf
Eingereicht: 23. August 2025
Angenommen: 16. Dezember 2025
Artikel online veröffentlicht:
24. Dezember 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Vázquez E, Macaya A, Mayolas N, Arévalo S, Poca MA, Enríquez G. Neonatal Alexander disease: MR imaging prenatal diagnosis. AJNR Am J Neuroradiol 2008; 29 (10) 1973-1975
- 2 Paprocka J, Nowak M, Machnikowska-Sokołowska M, Rutkowska K, Płoski R. Leukodystrophy with macrocephaly, refractory epilepsy, and severe hyponatremia-the neonatal type of Alexander disease. Genes (Basel) 2024; 15 (03) 350
- 3 Takeuchi H, Higurashi N, Kawame H. et al. GFAP variant p. Tyr366Cys demonstrated widespread brain cavitation in neonatal Alexander disease. Radiol Case Rep 2021; 17 (03) 771-774
- 4 Li R, Johnson AB, Salomons G. et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005; 57 (03) 310-326
- 5 Prust M, Wang J, Morizono H. et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 2011; 77 (13) 1287-1294
- 6 Springer S, Erlewein R, Naegele T. et al. Alexander disease–classification revisited and isolation of a neonatal form. Neuropediatrics 2000; 31 (02) 86-92
- 7 Singh N, Bixby C, Etienne D, Tubbs RS, Loukas M. Alexander's disease: reassessment of a neonatal form. Childs Nerv Syst 2012; 28 (12) 2029-2031
- 8 Mura E, Nicita F, Masnada S. et al. Alexander disease evolution over time: data from an Italian cohort of pediatric-onset patients. Mol Genet Metab 2021; 134 (04) 353-358
- 9 Knuutinen O, Kousi M, Suo-Palosaari M. et al. Neonatal Alexander disease: novel GFAP mutation and comparison to previously published cases. Neuropediatrics 2018; 49 (04) 256-261
- 10 Oikarainen JH, Knuutinen OA, Kangas SM. et al. Brain MRI findings in paediatric genetic disorders associated with white matter abnormalities. Dev Med Child Neurol 2024
- 11 van der Knaap MS, Salomons GS, Li R. et al. Unusual variants of Alexander's disease. Ann Neurol 2005; 57 (03) 327-338
- 12 van der Knaap MS, Naidu S, Breiter SN. et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22 (03) 541-552
- 13 Schwarz S, Steggerda SJ, de Vries LS. et al. Rapid progression and early mortality in neonatal-onset Alexander disease: association between clinical deterioration, cranial ultrasound and magnetic resonance imaging.
- 14 Dudink J, Jeanne Steggerda S, Horsch S. eurUS.brain group. State-of-the-art neonatal cerebral ultrasound: technique and reporting. Pediatr Res 2020; 87 (Suppl. 01) 3-12
- 15 Maller VV, Cohen HL. Neonatal head ultrasound: a review and update-part 1: techniques and evaluation of the premature neonate. Ultrasound Q 2019; 35 (03) 202-211
- 16 Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20 (01) 37-46
- 17 Kluyver T, Ragan-Kelley B, Pérez F. , et al , Eds. Jupyter Notebooks - a publishing format for reproducible computational workflows. International Conference on Electronic Publishing; 2016
- 18 Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE. Alexander disease. J Neurosci 2012; 32 (15) 5017-5023
- 19 Townsend JJ, Wilson JF, Harris T, Coulter D, Fife R. Alexander's disease. Acta Neuropathol 1985; 67 (1–2): 163-166
